A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer

Clinical trial NCT02826161 · TERMINATED

Trial details

NCT number: NCT02826161
Sponsor: Sumitomo Pharma America, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2016-11-01
Primary completion: 2017-04-24
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.